Fish AND lifestyle-related disease prevention: Experimental and epidemiological evidence for anti-atherogenic potential of taurine

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue SUPPL.2, 2004, Pages

  Yamori, Yukio ^a   Murakami, Shigeru ^a   Ikeda, Katsumi ^b   Nara, Yasuo ^c  

^a International Center for Research on Primary Prevention of Cardiovascular Diseases   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^c SHUJITSU UNIVERSITY   (Japan)

Author keywords

Atherogenesis; Hypercholesterolomia; Oxidative stress; Taurine; WHO CARDIAC study

Indexed keywords

ANTIOXIDANT; CHOLESTEROL 7ALPHA MONOOXYGENASE; IMMUNOLOGIC FACTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; TAURINE;

ANIMAL; ATHEROSCLEROSIS; BLOOD; CORONARY ARTERY DISEASE; DIET; FISH; GENE EXPRESSION; GENETICS; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE; METABOLISM; REVIEW; URINE;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CORONARY DISEASE; DIET; FISHES; GENE EXPRESSION; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOLOGIC FACTORS; LIFE STYLE; RECEPTORS, LDL; RNA, MESSENGER; TAURINE;

EID: 35948975647     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04122.x     Document Type: Review

References (30)

1. WHO and WHO Collaborating Centers. CARDIAC (Cardiovascular Diseases and Alimentary Comparison) Study Protocol. Shimane, Geneva. 1986.
2. Yamori Y. Environmental influences on the development of hypertensive vascular diseases in SHR and related models, and their relation to human disease. In: Worcel M, Bonvalet JP, Langer SZ, Menard J, Sassard J (eds). New Trends in Arterial Hypertension (INSERM Symposium No. 17). Elsevier, Amsterdam. 1981; 305-20.
3. Yamori Y, Nara Y, Mizushima S et al. International cooperative study on the relationship between dietary factors and blood pressure: A report from the cardiovascular diseases and alimentary comparison study. J. Cardiovasc. Pharmacol. 1990; 16: 43-7.
4. Okamoto K, Aoki K. Development of a strain spontaneously hypertensive rats. Jpn Circ. J. 1963; 27: 202-93.
5. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ. Res. 1974; 34: 1143-53.
6. Yamori Y. The stroke-prone spontaneously hypertensive rat: Contribution to risk factor analysis and prevention of hypertensive diseases. In: De Jong W (ed). Handbool of Hypertension, Vol. 4: Experimental and Genetic Models of Hypertension. Elsevier, Amsterdam. 1984; 240-55.
7. Yamori Y. Hypertension and biological dietary markers in urine and blood: A progress report from the cardiac study group. In: Yamori Y, Strasser T (eds). New Horizons in Preventing Cardiovascular Diseases. Elsevier, Amsterdam. 1989; 111-26.
8. Yamori Y, Horie R, Nara Y et al. Pathogenesis and dietary prevention of cerebrovascular diseases in animal models and epidemiological evidence for the applicability in man. In: Yamori Y, Lenfant C (eds). Prevention of Cardiovascular Diseases, an Approach to Active Long Life. Elsevier, Amsterdam. 1987; 163-77.
9. Nara Y, Yamori Y, Lovenberg W. Effects of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem. Pharmacol. 1978; 27: 2689-92.DOI: 10.1016/0006-2952(78)90043-6
10. Sato Y, Ogata E, Fujita T. Hypotensive action of taurine in DOCA-salt rats-involvement of sympathoadrenal inhibition and endogenous opiate. Jpn Circ. J. 1991; 55: 500-8.
11. Ikeda K, Nara Y, Horie R, Yamori Y. Diets modify pressor and catecholamine responses to stress in stroke-prone spontaneously hypertensive rats (SHRSP). In: Yamori Y, Strasser T (eds). New Horizons in Preventing Cardiovascular Diseases. Elsevier, Amsterdam. 1989; 23-5.
12. Mizushima S, Nara Y, Sawamura M, Yamori Y. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv. Exp. Med. Biol. 1996; 403: 615-22.
13. Murakami S, Nara Y, Yamori Y. Taurine accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats. Life Sci. 1996; 58: 1643-51.DOI: 10.1016/0024-3205(96)00139-7
14. Jerlich A, Fritz G, Kharrazi H et al. Comparison of HOCL traps with mycloperoxidase inhibitors in prevention of low density lipoprotein oxidation. Biochem. Biophys. Acta 2000; 1481: 109-18.
15. Huxtable RJ. Physiological actions of taurine. Physiol. Rev. 1992; 72: 101-63.
16. Huxtable RJ. Expanding the circle 1975-1999: Sulfur biochemistry and insights on the biological functions of taurine. Adv. Exp. Med. Biol. 2000; 483: 1-25.
17. Tsuji K, Yano S. Taurine/cholesterol ratio of well-consumed animal foods. Sulfur Amino Acids 1984; 7: 249-55.
18. Schuller-Levis GB, Park E. Taurine and its chloramine: Modulators of immunity. Neurochem. Res. 2004; 29: 117-26.DOI: 10.1023/B:NERE.0000010440.37629.17
19. Yamori Y, Nara Y, Ikeda K, Mizushima S. Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition?. Adv. Exp. Med. Biol. 1996; 403: 623-9.
20. Yamori Y, Liu L, Ikeda K et al. Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations 11 countries' results from the WHO-CARDIAC Study. Hypertens. Res. 2001; 24: 453-7.DOI: 10.1291/hypres.24.453
21. Yamori Y, Nara Y, Mizushima S et al. Gene-environment interaction in hypertension, stroke and atherosclerosis in experimental models and supportive findings from a world-wide cross-sectional epidemiological survey: A WHO-CARDIAC Study. Clin. Exp. Pharmacol. Physiol. 1992; 19: 43-52.
22. Mizushima S, Moriguchi EH, Nakada Y et al. The relationship of dietary factors to cardiovascular diseases among Japanese in Okinawa and Japanese immigrants, originally from Okinawa, in Brazil. Hypertens. Res. 1992; 15: 45-55.
23. Yamori Y, Hamashima Y, Horie R, Handa H, Sato M. Pathogenesis of acute arterial fat deposition in spontaneously hypertensive rats. Jpn Circ. J. 1975; 39: 601-9.
24. Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high cholesterol diet. J. Nutr. 1999; 129: 1705-12.
25. Murakami S, Kondo Y, Toda Y et al. Effect of taurine on cholesterol metabolism in hamsters: Up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci. 2002; 70: 2355-66.DOI: 10.1016/S0024-3205(02)01507-2
26. Kondo Y, Toda Y, Kitajima H et al. Taurine inhibits development of atherosclerolic lessons in apolipoprotein E-deficient mice. Clin. Exp. Pharm. Phpial. 2001; 28: 809-15.DOI: 10.1046/j.1440-1681.2001.03527.x
27. Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T. Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atheroschlerosis 2002; 163: 79-87.DOI: 10.1016/S0021-9150(01)00764-X
28. Penn MS, Chisoim GM. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis 1994; 108: 21-9.
29. Alexander RW. Theodore Cooper Memorial Lecture: Hypertension and the pathogenesis of atherosclerosis, oxidative stress and the mediation of arterial inflammatory response, a new perspective. Hypertension 1995; 25: 155-61.
30. Jacobsen JG, Smith LH. Biochemistry and physiology of taurine and taurine derivatives. Physiol. Rev. 1968; 48: 424-511.